WebSignaling profiles were assessed through an automated platform using our bioSensAll® technology, which measures the activity of various signaling pathways using a panel of 16 selective... WebDr. Meriem Semache, a scientist at Domain Therapeutics NA, will provide an overview on bioSensAll®, an enhanced bystander bioluminescence resonance energy transfer …
BIOSENSALL Trademark of Domain Therapeutics. Serial …
Web21 Feb 2024 · Domain Therapeutics NA’s activities focus on leveraging Domain’s bioSensAll™ technology through:Research collaborations on the discovery of … Web14 Dec 2016 · Domain Therapeutics, a France- and Quebec-based biopharmaceutical company that specializes in the research and development of new drug candidates that target G protein-coupled receptors (GPCRs),... texas ranch for lease
bioSensAll European Pharmaceutical Manufacturer
WebbioSensAll is a trademark and brand of Domain Therapeutics, Illkirch Graffenstaden 67400, FRANCE. This trademark was filed to EUIPO on Friday, January 17, 2014. The bioSensAll is under the trademark classification: Chemical Products; Computer & Software Services & Scientific Services; The bioSensAll trademark covers Chemicals, or biological or natural … http://www.drgpcr.com/dr-gpcr-summit-2024-schedule/advancing-gpcr-drug-discovery-with-biosensall-platform-technology/ WebThe bioSensAll® biosensor platform provides a qualitative and quantitative assessment of a receptor’s complete signaling repertoire and allows for the identification and characterization of biased ligands in a rapid, simple and homogenous assay. Ultimately, a ligand’s signaling signature may be useful in texas ranch gear